Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$158.6M
48M shares
52-week range
$2.56 – $7.32
19% from low
Sector
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Exchange
NASDAQ
CS
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
www.lifemd.comNo one on the platform currently holds LFMD.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,118,325 | $4.0M |
No one on the platform has traded LFMD yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$LFMD They should have sold the telehealth business and kept WorkSimpli.
View on StockTwits ↗$LFMD depending on the model, this trades at a 20-80% discount. Margin of safety and upside in 2027 once peptides start to show in the numbers
View on StockTwits ↗$LFMD I don’t understand why investors keep trusting this company. They aren’t truthful and haven’t improved in years. file:///var/mobile/Library/SMS/Attachments/61/01/2872EFFA-AA43-4C10-A2AF-DBBFC693539E/LifeMD,%20a%20popular%20telehealth%20firm,%20put%20...ts%20over%20patient%20safety,%20ex-workers%20say.pdf
View on StockTwits ↗$LFMD Was anyone around in 2022/2023 when they lowered guidance like three times in one year and STILL misssd it by a big margin ? And people still have faith in this company. According to Marc the company was supposed to be EPS positive like 2 years ago. It boggles my mind that some investors still trust these people. And I’m not saying they are crooked/liars, just extremely incompetent.
View on StockTwits ↗$LFMD no reason to not be unprofitable this quarter. they have pharma in 50 states. all the new programs have been rolled out. they spent all the money into a big negative 1st quarter. obviously the ceo doesnt know his market. and the cfo last year selling at a pumped up high of almost 16 before the big crash. and right before he was leaving. also the ceo selling stock monthly up to right before the crash. all suspicious. they keep saying next year after next year. it never goes up. they just keep diluting shares and spending cash with nothing to show for it. the only thing profitable, which was also a scam, was work simpli. all that money will be gone soon. even this company has tons of negative reviews with predatory subscriptions and tons of people unhappy. Justin keeps talking about what great care. I dont see it. gaslighting at best.
View on StockTwits ↗$LFMD The worst is over and you're all selling at the bottom. They've been guiding this path, even if it's a little worse than what they projected, it also means Q4+ will be profitable.
View on StockTwits ↗$LFMD knew it got to be too cheap, this is not a $3 stock, grab it when it has a bad quarter, it has gone to 10-12 many times for those long term owners here
View on StockTwits ↗$LFMD just increased my position at 3.19, like the price point a lot for risk/reward here.
View on StockTwits ↗$LFMD Burning obscene amounts of cash, declining revenue, declining subscriber numbers. Shouldn’t revenue be booming right now?
View on StockTwits ↗$LFMD Alex1965 blocked me so i can’t see how he is framing this ER positively. Can someone screenshot and share?
View on StockTwits ↗$HIMS $LFMD touting 89% gross margins is like peacocking a luxury rental car. 1. Lost subscribers this quarter. 2. Reported less telehealth revenue YOY 3. Only have 25 million in cash left. 5 of which must remain in the bank as part of a debt covenant. 4. Revised down both their yearly revenue and EBITDA
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $217M | -7.2% | $-0.43 | $-0.55–$-0.31 | — | 3 |
| 2027 | $256M | +17.8% | $-0.00 | $-0.00–$0.00 | — | 3 |
| 2028 | $296M | +15.5% | $0.24 | $0.17–$0.28 | 14.6× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| LFMDLifeMD, Inc. | $3.46 | +5.17% | $167M | — |
| CERSCerus Corporation | $2.84 | +4.80% | $572M | — |
| CVRXCVRx, Inc. | $2.94 | +7.69% | $78M | — |
| HITIHigh Tide Inc. | $2.32 | -0.43% | $204M | — |
| MASS908 Devices Inc. | $10.11 | +0.90% | $415M | — |
| OMIOwens & Minor, Inc. | $2.68 | +8.94% | $207M | — |
| SENSSenseonics Holdings, Inc. | $7.73 | -2.52% | $323M | — |
Source: Financial Modeling Prep · peers by sector/industry